Aarti Drugs surged 7.57% to Rs 606.35 after the pharma company announced that its board has approved share buyback of up to Rs 59.85 crore at a price of Rs 900 per equity share.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.